Uriviga 600 Tablet contains Flavoxate 600mg, a smooth muscle relaxant used for urinary tract disorders, including bladder spasms, dysuria, and frequency. By relieving involuntary bladder contractions, it provides effective symptom control and improves patient comfort.
This tablet has high prescriber trust due to its consistent efficacy and tolerability, making it a frequently recommended product in urology practices. Its reliable performance ensures strong patient adherence and repeat demand.
For franchise partners, Uriviga 600 Tablet represents a high-demand urinary care therapy product. Its therapeutic reliability and market acceptance make it a profitable addition to your urology portfolio, supporting business growth and customer retention.
With its proven clinical efficacy and consistent demand, Uriviga 600 Tablet is an excellent choice for partners looking to expand into urinary care and bladder health markets, driving steady sales and business profitability.
Common side effects may include dry mouth, blurred vision, dizziness, nausea, headache, and mild gastrointestinal disturbances. Rarely, patients may experience palpitations, constipation, or allergic reactions. Severe side effects should be reported to a healthcare professional immediately.
Uriviga 600 Tablet is indicated for the treatment of urinary bladder spasm, dysuria, and urinary frequency associated with infections, inflammation, or post-surgical conditions. It helps improve patient comfort by reducing involuntary bladder contractions and associated urinary discomfort.
Uriviga 600 Tablet should be taken exactly as prescribed, preferably after meals to reduce gastrointestinal irritation. Caution is advised in patients with glaucoma, urinary retention, severe kidney or liver disorders. Avoid exceeding the recommended dose.
Store Uriviga 600 Tablet in a cool, dry place, protected from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date indicated on the pack.